78 filings
Page 4 of 4
8-K
ry3a7h6n
17 Oct 14
Departure of Directors or Certain Officers
12:00am
8-K
9gn2tzkm
26 Sep 14
Regulation FD Disclosure
12:00am
8-K/A
pkh6l6w6z5
24 Sep 14
Departure of Directors or Certain Officers
12:00am
8-K
vg02gre
22 Sep 14
Entry into a Material Definitive Agreement
12:00am
8-K
2q32iv dsu5b9h82c2
19 Sep 14
Departure of Directors or Certain Officers
12:00am
8-K
ew71sx48aou935o
18 Sep 14
Acucela To Present at the BioCentury NewsMakers in the Biotech Industry Conference
12:00am
8-K
6dxjx3dys6kbz
9 Sep 14
Departure of Directors or Certain Officers
12:00am
8-K
pyjd0828
14 Aug 14
Results of Operations and Financial Condition
12:00am
8-K
phehbpwjt4yi
12 Aug 14
Revisions to Earnings Forecasts
12:00am
8-K
7nzksdrp01
1 Jul 14
Entry into a Material Definitive Agreement
12:00am
8-K
0owt5q
6 Jun 14
Submission of Matters to a Vote of Security Holders
12:00am
8-K
ar9 641nw3
2 Jun 14
Regulation FD Disclosure
12:00am
8-K
hwm hhws8
20 May 14
Regulation FD Disclosure
12:00am
8-K
5tfof81b7cq426ex2i
15 May 14
Results of Operations and Financial Condition
12:00am
8-K
y94unoy5n8jpqj1pg
9 May 14
Acucela Provides Update on Emixustat Hydrochloride Clinical Development Program
12:00am
8-K
ti6oxaqkfdz03ob
26 Mar 14
Results of Operations and Financial Condition
12:00am
8-K
bep3zrg1
4 Mar 14
Acucela Completes Enrollment in the Emixustat Hydrochloride Phase 2b/3 Clinical Trial
12:00am
8-K
u19 7jxplzlgfof8
13 Feb 14
Results of Operations and Financial Condition
12:00am